Search Results

3 results

  1. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 068

    The scientific evidence for the proposed NNN standard

    MARANO K.M.(1); LIU C.(1); CURTIN G.M.(1); PARMS T.(1); BACHAND A.(2); SULSKY S.I.(2); MARIANO G.(2); GREENE T.(3); GENTRY P.R.(3)
    (1) RAI Services Company, Winston-Salem, NC; USA; (2) Ramboll Environ, Amherst, MA, USA; (3) Ramboll Environ, Monroe, LA, USA
    The US Food and Drug Administration (FDA) published a proposed standard of 1 µg/g (dry weight) N-nitrosonornicotine (NNN) in finished smokeless tobacco (ST) products. FDA’s rationale for the standard is that NNN is a potent carcinogen, NNN is a major ...
  2. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 110

    Modeling the population health effects of Camel snus with reduced risk information

    (1) Ramboll Environ U.S., Amherst, MA, USA; (2) Pinney Associates, Pittsburgh, PA, USA; (3) RAI Services Company, Winston-Salem, NC, USA
    We present findings from a statistical model, used to assess the population health effects of Camel Snus with reduced risk information. Analyses followed a single cohort of 1 million males from age 13 to age 72, comparing the number of survivors in a base ...